Startup is focused on reprogramming the epigenome – a network of chemical compounds and proteins that control cell functions by influencing which genes are active – to restore capabilities that are often lost with age.
What you get
The solution uses many years of development in this area by Stanford University scientists (several patents are licensed).
Terms of completing
At the moment, the decision is at the stage of preclinical testing and is confirmed by experiments on human tissue models and on animals.
To: Investing with Network VC Syndicate Fund in Turn Bio